These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37081671)

  • 41. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.
    Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H
    Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas.
    Hiti AL; Bogenmann E; Gonzales F; Jones PA
    Mol Cell Biol; 1989 Nov; 9(11):4722-30. PubMed ID: 2601695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma.
    Kappler R; Bauer R; Calzada-Wack J; Rosemann M; Hemmerlein B; Hahn H
    Oncogene; 2004 Nov; 23(54):8785-95. PubMed ID: 15480423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice.
    Price RL; Bingmer K; Harkins L; Iwenofu OH; Kwon CH; Cook C; Pelloski C; Chiocca EA
    Cancer Res; 2012 Nov; 72(22):5669-74. PubMed ID: 23002204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perianal and perineal rhabdomyosarcomas: a retrospective multicenter study of 35 cases.
    Guo Y; Hu B; Huang D; Wang X; Li J; Zhang D; Li X; Chen G; Ren D
    BMC Surg; 2021 Jan; 21(1):66. PubMed ID: 33516222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis.
    Scholl FA; McLoughlin P; Ehler E; de Giovanni C; Schäfer BW
    J Cell Biol; 2000 Oct; 151(3):495-506. PubMed ID: 11062252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic modeling of Ras-induced human rhabdomyosarcoma.
    Linardic CM; Counter CM
    Methods Enzymol; 2008; 438():419-27. PubMed ID: 18413264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pleomorphic rhabdomyosarcoma in a cow.
    Aoyagi T; Saruta K; Asahi I; Hojo H; Shibahara T; Kadota K
    J Vet Med Sci; 2001 Jan; 63(1):107-10. PubMed ID: 11217054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
    Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Furihata M; Ohtsuki Y
    Int J Oncol; 2000 Jul; 17(1):119-25. PubMed ID: 10853028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway.
    Schwarzkopf M; Coletti D; Sassoon D; Marazzi G
    Genes Dev; 2006 Dec; 20(24):3440-52. PubMed ID: 17182869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells.
    Hettmer S; Liu J; Miller CM; Lindsay MC; Sparks CA; Guertin DA; Bronson RT; Langenau DM; Wagers AJ
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20002-7. PubMed ID: 22135462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical Characterization of Sarcomas in Trp53+/- Haploinsufficient Mice.
    Jokinen MP; Morgan DL; Price HC; Herbert RA; Saddler T; Dixon D
    Toxicol Pathol; 2017 Aug; 45(6):774-785. PubMed ID: 29046139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Fusion Transcription Factor-Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target.
    Boudjadi S; Pandey PR; Chatterjee B; Nguyen TH; Sun W; Barr FG
    Cancer Res; 2021 Jun; 81(11):2930-2942. PubMed ID: 33589519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content.
    Park JY; Wang PY; Matsumoto T; Sung HJ; Ma W; Choi JW; Anderson SA; Leary SC; Balaban RS; Kang JG; Hwang PM
    Circ Res; 2009 Sep; 105(7):705-12, 11 p following 712. PubMed ID: 19696408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of a regenerative microenvironment in skeletal muscle is sufficient to induce embryonal rhabdomyosarcoma in p53-deficient mice.
    Camboni M; Hammond S; Martin LT; Martin PT
    J Pathol; 2012 Jan; 226(1):40-9. PubMed ID: 21915858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nasal pleomorphic adenoma with skeletal muscle differentiation: potential misdiagnosis as rhabdomyosarcoma.
    Lam PW; Chan JK; Sin VC
    Hum Pathol; 1997 Nov; 28(11):1299-302. PubMed ID: 9385937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.
    Skoda J; Nunukova A; Loja T; Zambo I; Neradil J; Mudry P; Zitterbart K; Hermanova M; Hampl A; Sterba J; Veselska R
    Tumour Biol; 2016 Jul; 37(7):9535-48. PubMed ID: 26790443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.
    Cocker HA; Pinkerton CR; Kelland LR
    Br J Cancer; 2000 Aug; 83(3):338-45. PubMed ID: 10917549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Establishment and characterization of canine rhabdomyosarcoma cell line CMS-C.
    Azakami D; Shibutani H; Dohi M; Takasaki M; Ishioka K; Mori A; Momota Y; Bonkobara M; Washizu T; Michishita M; Hatakeyama H; Ogasawara S; Sako T
    J Vet Med Sci; 2011 Aug; 73(8):1105-8. PubMed ID: 21519159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
    Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
    Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.